LQDA Live signals | Maximize Profits with Getagraph.com

SELL 94729 min ago

@ $14.38

Issued: 13 Feb 2024 @ 15:39

Return: -4.87%

Previous signal: Feb 12 - 13:44

Previous signal: Buy

Return: -3.07 %

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:28):

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States...

Stats
Today's Volume	103 679
Average Volume	882 743
Market Cap	1.04B
EPS	$0 ( 2024-03-13 )
Next earnings date	( $-0.320 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.31
ATR14	$0.0130 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-12	Schundler Russell	Sell	2 060	Common Stock
2024-04-12	Saggar Rajeev	Sell	1 525	Common Stock
2024-04-12	Moomaw Scott	Sell	1 585	Common Stock
2024-04-12	Kaseta Michael	Sell	3 136	Common Stock
2024-04-12	Jeffs Roger	Sell	8 360	Common Stock

INSIDER POWER
76.71
Last 99 transactions
Buy: 2 740 961 \| Sell: 337 688

Volume Correlation

Long: 0.21 (neutral)

Short: 0.66 (moderate)

Signal:(25.927) Neutral

Liquidia Technologies Inc Correlation

10 Most Positive Correlations
ISEM	0.873
IDLB	0.86
ALOR	0.855
ACAH	0.844
HTHT	0.841
EVOP	0.839
CRNC	0.827
RCM	0.827
PATK	0.826
BSGM	0.824

10 Most Negative Correlations
CMLFU	-0.877
EMBCV	-0.849
IRBT	-0.838
MAGS	-0.835
BOWXU	-0.833
HOLUU	-0.824
PROG	-0.824
ASPS	-0.821
FTOCU	-0.819
RMCF	-0.819

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Liquidia Technologies Inc Correlation - Currency/Commodity

0.17
( neutral )

0.22
( neutral )

0.00
( neutral )

0.20
( neutral )

-0.49
( neutral )

0.24
( neutral )

Liquidia Technologies Inc Financials

Annual	2023
Revenue:	$17.49M
Gross Profit:	$13.42M (76.75 %)
EPS:	$-1.210

Q4	2023
Revenue:	$4.53M
Gross Profit:	$3.26M (71.95 %)
EPS:	$-0.420

Q3	2023
Revenue:	$3.68M
Gross Profit:	$3.11M (84.50 %)
EPS:	$-0.240

Q2	2023
Revenue:	$4.79M
Gross Profit:	$4.12M (85.98 %)
EPS:	$-0.360

Financial Reports:

No articles found.

Liquidia Technologies Inc

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.